What Researchers Did
Researchers retrospectively analyzed the medical records of 92 hospitalized patients diagnosed with Clostridioides difficile infection to see if hyperbaric oxygen therapy affected their outcomes.
What They Found
The study found that patients who received hyperbaric oxygen therapy had a significantly lower recurrence rate of Clostridioides difficile infection (0%) compared to those who did not (22.4%). Additionally, the symptomatic period for patients receiving hyperbaric oxygen therapy was notably shorter, averaging 6.2 days compared to 13.6 days for the control group.
Canadian Relevance
This study was not conducted by Canadian authors or in Canada. Clostridioides difficile infection is not currently a Health Canada-recognised indication for hyperbaric oxygen therapy.
Study Limitations
This was a retrospective study where hyperbaric oxygen therapy was given for other medical conditions, not directly for the Clostridioides difficile infection itself, which limits the direct applicability of these findings.